Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

NCT02042170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Establishing Dose of Sr-hGH in ISS Patients

Interventions

DRUG: human growth hormone self-injection

Sponsor

LG Life Sciences